Citius Pharmaceuticals CTXR
NASDAQ CTXR
$0.40 +0.03 (+7.30%)
As of: Oct 23, 2026 · 3:59 PM EDT

Citius Pharmaceuticals (CTXR) Return on Assets [ROA] (2011 - 2026)

Updated

Citius Pharmaceuticals (CTXR) recorded Return on Assets [ROA] of -42.33% in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 8.56 percentage points from -33.77% a year earlier and down 1.70 percentage points from the prior quarter.

Analysis

Citius Pharmaceuticals (CTXR) Return on Assets [ROA] (2011 - 2026) Analysis & Trends

For FY2025 (ended Sep 30, 2025), Citius Pharmaceuticals reported Return on Assets [ROA] of -32.10%, up 3.70 percentage points from FY2024.

  • Annual Return on Assets [ROA] has a five-year change of +11.49 percentage points (FY2020 to FY2025).
  • Across earlier fiscal years, Return on Assets [ROA] came in at -35.80% in FY2024 (-5.89 pp), -29.91% in FY2023 (-3.67 pp), -26.24% in FY2022 (-1.48 pp) and -24.76% in FY2021 (+18.82 pp).
  • The fiscal Q3 2026 figure is the lowest quarterly Return on Assets [ROA] since fiscal Q1 2021.
  • On a year-over-year basis, Return on Assets [ROA] rose in five of the last eight quarters, with an average year-over-year change of +0.67 percentage points.
  • Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 36.65 percentage points in fiscal Q1 2022, against a drop of 13.68 percentage points in fiscal Q1 2024 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at -40.63% (Q2 2026), -28.64% (Q1 2026) and -30.73% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 8.08%
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 4.65%
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 2.45%
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 10.60%
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 9.10%
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 9.29%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -6.13%
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 2.14%
10 Citius Pharmaceuticals 10.47 Mn -23.10 Mn 1.00 Mn -42.33%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -42.33%
Mar 31, 2026 -40.63%
Dec 31, 2025 -28.64%
Sep 30, 2025 -30.73%
Jun 30, 2025 -33.77%
Mar 31, 2025 -35.88%
Dec 31, 2024 -34.11%
Sep 30, 2024 -36.89%
Jun 30, 2024 -40.78%
Mar 31, 2024 -38.49%
Dec 31, 2023 -37.99%
Sep 30, 2023 -30.41%
Jun 30, 2023 -27.97%
Mar 31, 2023 -28.15%
Dec 31, 2022 -24.31%
Sep 30, 2022 -28.22%
Jun 30, 2022 -24.81%
Mar 31, 2022 -20.96%
Dec 31, 2021 -17.40%
Sep 30, 2021 -16.11%
API Access

Citius Pharmaceuticals Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=CTXR&period=max&api_key=YOUR_API_KEY